Topics

Diffuse midline glioma | Overall management | Overview

Home > Publications > Topics > Diffuse midline glioma > Overall management > Overview

2024

Tosi U, Souweidane M.
Diffuse Midline Gliomas: Challenges and New Strategies in a Changing Clinical Landscape.
Cancers (Basel). 2024 Jan 2;16(1):219. doi: 10.3390/cancers16010219. PMID: 38201646. Review. ˍ

Akdemir EY, Odia Y, Hall MD, Mehta MP, Kotecha R.
An Update on H3K27M-altered Diffuse Midline Glioma: Diagnostic and Therapeutic Challenges in Clinical Practice.
Pract Radiat Oncol. 2024 May 3:S1879-8500(24)00094-8. doi: 10.1016/j.prro.2024.04.013. PMID: 38704025. Guidelines˰ ˍ

2026

Bihari S, Yang D, Mukherji D, Haggiagi A.
Diffuse Midline Gliomas: Clinical, Diagnostic, and Therapeutic Perspectives.
Biomedicines. 2026 Apr 20;14(4):934. doi: 10.3390/biomedicines14040934. PMID: 42072474. ˍ

Iglesias S, Becerra V, Miranda P, Márquez T, Galbarriatu L, Munarriz PM, Gimenez J, Saceda J, Rius F, Hinojosa J.
Clinical, molecular, and surgical predictors of outcome in non-DIPG pediatric diffuse midline gliomas: A collaborative retrospective analysis.
Childs Nerv Syst. 2026 Aug 20;42(1):341. doi: 10.1007/s00381-026-07432-4. PMID: 42622932˰ ˍ